• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of adenosine on sympathetic vasoconstriction in dog gracilis muscle.

作者信息

Klabunde R E

出版信息

J Pharmacol Exp Ther. 1987 Jan;240(1):106-10.

PMID:3100763
Abstract

The effects of intra-arterial infusions of adenosine (ADO) on sympathetic vasconstrictor responses were studied in the gracilis nerve-muscle preparation of the dog under constant flow conditions. Sympathetic nerves to the muscle were activated at a frequency of 1 Hz for 2 min during infusions of ADO, 2-chloroadenosine, nitroglycerine or hydralazine. ADO concentrations of 1, 10 and 50 microM decreased perfusion pressure by 19, 42 and 57 mm Hg, respectively, from a control (saline infusion) perfusion pressure of 110 mm Hg. Sympathetic vasoconstrictor responses were attenuated only at 50 microM ADO. Sympathetic responses during 1 and 10 microM ADO infusion were the same as during infusion of 10 and 100 microM nitroglycerine, which produced the same degree of vasodilation as 1 and 10 microM ADO, respectively. Except for greater vasodilator potency, 2-chloroadenosine infusions produced effects similar to ADO. Infusion of hydralize produced concentration-dependent decreases in control perfusion pressure and sympathetic vasoconstrictor responses. These results indicate that intra-arterial administration of ADO or one of its stable analogs (2-chloroadenosine) does not cause inhibition of sympathetic vasoconstrictor responses except at concentrations that cause nearly maximal vasodilation.

摘要

相似文献

1
Effects of adenosine on sympathetic vasoconstriction in dog gracilis muscle.
J Pharmacol Exp Ther. 1987 Jan;240(1):106-10.
2
Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog.肾内腺苷通过激活犬肾神经的交感神经系统来产生高血压。
J Hypertens. 1984 Aug;2(4):349-59.
3
Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.神经肽Y与去甲肾上腺素在外周交感神经血管控制中的共同释放及功能相互作用。
Acta Physiol Scand Suppl. 1988;568:1-56.
4
Adenosine affects sympathetic neurotransmission at multiple sites in vivo.腺苷在体内多个部位影响交感神经传递。
J Pharmacol Exp Ther. 1986 Feb;236(2):350-5.
5
Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.关于神经肽Y、血管活性肠肽和一氧化氮的非肾上腺素能、非胆碱能血管控制
Acta Physiol Scand Suppl. 1994;622:1-74.
6
Effect of neuronal uptake blockade on the amplifying effect of serotonin on sympathetic vasoconstriction in rat autoperfused hindlimb.神经元摄取阻断对5-羟色胺增强大鼠自体灌注后肢交感神经血管收缩作用的影响。
J Cardiovasc Pharmacol. 1987;10 Suppl 3:S65-8.
7
Mechanism of action of prostaglandin E2 in the dog skeletal muscle circulation.
Chin Med J (Engl). 1998 Oct;111(10):945-50.
8
Influence of adenosine on the vascular responses to sympathetic nerve stimulation in the canine subcutaneous adipose tissue.腺苷对犬皮下脂肪组织中交感神经刺激引起的血管反应的影响。
Acta Physiol Scand. 1983 Sep;119(1):15-24. doi: 10.1111/j.1748-1716.1983.tb07300.x.
9
Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.神经肽Y在肾交感神经血管收缩中的作用:对正常及充血性心力衰竭大鼠的研究
J Lab Clin Med. 2001 Aug;138(2):119-29. doi: 10.1067/mlc.2001.116715.
10
BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.BIBP 3226、苏拉明和哌唑嗪确定神经肽Y、5'-三磷酸腺苷和去甲肾上腺素为大鼠肠系膜动脉床中的交感神经共同递质。
J Pharmacol Exp Ther. 1997 Aug;282(2):691-8.

引用本文的文献

1
Multi-level Influences on Breast Cancer Screening in Primary Care.多层次影响初级保健中的乳腺癌筛查。
J Gen Intern Med. 2018 Oct;33(10):1729-1737. doi: 10.1007/s11606-018-4560-1. Epub 2018 Aug 3.